If you missed out on the 2025 NO Laminitis! Conference last November, you still have a chance to access these great presentations.
Video recordings are available for the Equine Cushing’s and Insulin Resistance Group Inc.’s 2025 NO Laminitis! Conference. You can subscribe now for $300 USD. This subscription opportunity will close on April 3, 2026, at midnight ET (New York, USA).
All 21 conference lectures and Q&A sessions are included (25 hours total).
Purchase through PayPal with your PayPal account, or check out as a PayPal guest with your credit or debit card or Venmo.
Recordings will be available via a dedicated on-demand link for six months from date of purchase.
View the full conference program: https://www.nolaminitis.org/conference-schedule.php
Direct link to subscription: https://www.nolaminitis.org/conference-video-subscribe.php
Presenters Are:
- Robert M. Bowker, VMD, PhD
- Johan Bröjer, DVM, MSc, PhD, Dipl. ACVIM (LAIM), Dipl. ECEIM
- Priska Darani, PhD, PAS
- Suzanne Gottschang, PhD, MPH
- Kathleen Gustafson, PhD
- Jo Ireland BVMS PhD CertAVP(EM) FHEA FRCVS
- Eleanor M. Kellon, VMD
- Elaine Norton, DVM, MS, PhD, DACVIM-LA
- David Rendle, BVSc MVM CertEM, DipECEIM, FRCVS
- Harold C. Schott, DVM, PhD, DACVIM
- Kathleen Sullivan, PhD, MS
- Tania Sundra, BSc (Hons) BVMS MANZCVS (Equine Medicine)
Topics Include:
- Hypertriglyceridemia With SGLT2i — Biochemistry and Management
- Factors Affecting ACTH Concentration and Implications for Endocrine Diagnostic Testing
- Is the Blood Supply to the Frog and Digital Cushion, as the Anatomy Books State, Scant?
- Risk of Equine Metabolic Syndrome in Arabian Horses and Their Subgroups
- Pergolide Dosage and Other ECIR Poll Results
- Obesity, Hyperinsulinemia, and the Curse of Laminitis
- Loading of the Foot Can and Will Alter the Shape and Structures of the Digital Bones
- Is PPID Parkinson’s Disease of Equids?
- Mechanisms Leading to Hypertriglyceridemia in SGLT2-treated Horses (ECIR-Funded Research)
- Nutrition Considerations for Equine Hyperinsulinemia
About ECIR Group Inc.
Celebrating 25 years, the ECIR Group is the largest field-trial database for PPID and EMS in the world and provides the latest research, diagnosis, and treatment information, in addition to dietary recommendations for horses with these conditions. The ECIR Group has the unique ability to compile and follow long term many in-depth case histories of PPID/EMS horses.
In 2013 the Equine Cushing’s and Insulin Resistance Group Inc., an Arizona nonprofit corporation, was approved as a 501(c)3 public charity. Tax deductible contributions and grants support ongoing research, education, and awareness of Equine Cushing’s Disease/PPID and EMS.
THE MISSION of the ECIR Group Inc. is to improve the welfare of equines with metabolic disorders via a unique interface between basic research and real-life clinical experience. Prevention of laminitis is the ultimate goal. The ECIR Group serves the scientific community, practicing clinicians, and owners by focusing on investigations most likely to quickly, immediately, and significantly benefit the welfare of the horse.
Your contributions support ongoing education and awareness of Equine Cushing’s Disease and Insulin Resistance. https://www.ecirhorse.org/how-to-help-ECIR.php
Stay in the know! Sign up for EquiManagement’s FREE weekly newsletters to get the latest equine research, disease alerts, and vet practice updates delivered straight to your inbox.
